4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-060093
Chief Executive Officer gave up 19,401 shares (to pay taxes)
- Chief Executive Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2022-12-03 | Option exercise | +40,000 | 330,279 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2022-12-05 | Shares withheld for taxes | −19,401 | $52.26 | $1,013,896 | 310,878 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2022-12-03 | Option exercise · Restricted Stock Units | +40,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…